Barclays China CEO Liu Yang: Business adjustments have little impact on Asia. This year, bond products will become more diversified and complex
胡胡胡美丽_ss
发表于 2024-3-20 18:03:39
221
0
0
Barclays Group has updated its development strategy for the first time in nearly a decade.
This top UK bank will restructure its business into five operational departments, enhance departmental performance disclosure, and enhance accountability from an operational and management perspective. And will return £ 10 billion to shareholders between 2024 and 2026, with the goal of achieving a tangible return on equity of over 10% by 2024 and an increase to over 12% by 2026.
How much impact will the above business adjustments have on Barclays Bank China? How is the business development in China? In response to the above issues, Interface News interviewed Liu Yang, CEO of Barclays Bank in China.
Liu Yang joined Barclays in 2021 and is currently responsible for Barclays China's business, including investment banking, commercial banking, and financial markets, as well as financial market sales in Asia excluding Japan.
In the interview, Liu Yang also talked about the licensing issue of Barclays China and the "tactics" for 2024.
Interface News: What impact will this business adjustment have on the China region?
Liu Yang: The adjusted global business line has been divided into five departments, namely UK Retail Banking, UK Corporate Banking, Private Banking and Wealth Management, US Credit Card Business, and Investment Banking. The investment banking business includes corporate banking outside the UK, global financial markets, and investment banking. In fact, the product line in Asia has always been in this model, and the UK and the US have been most affected by business line adjustments, with little impact on the layout or structure of Asian business.
Interface News: What is Barclays' positioning for development in China?
Liu Yang: The return on equity and tangible return on equity of Barclays Greater China in 2023 are much higher than the average of the entire group. The overall transaction revenue of Chinese products has shown significant growth.
Investment decisions must be localized. For foreign financial institutions, whether it is for regulatory or economic environments, the specific localization of the market and the subtle differences in the local market are very important. It's difficult for our headquarters in other countries to suddenly have insight, decision-making power, or complete knowledge of what's really happening in the market.
"Bridge" has always been the positioning of Barclays China. Perhaps in the next five years, our development scale and overall competitiveness in China may not be comparable to state-owned banks or top foreign-funded banks, but we firmly adhere to a long-term approach.
Interface News: However, based on Barclays' business layout in China, the company has not made actual progress in licensing yet. Are there any considerations for licensing in the future?
Liu Yang: Within the framework of Barclays China's business planning, we have continuously received regulatory support for the official launch of new products in the past two years, and we will continue to complete the launch of new products in 2024. This year, we will first expand and strengthen the most basic platform within the scope of our existing license business.
Interface News: Faced with the current phenomenon of IPO cooling in the financial market and the increasing popularity of big asset management and big wealth management, what new "tactics" does Barclays have?
Liu Yang: This year's adjusted organizational structure has a new private banking and wealth management department, mainly located in the UK, and mainly in India and Singapore in Asia.
In 2023, the savings of households in China have increased significantly, which is a process of rebalancing. Because many funds were originally invested in real estate, ordinary investors may now prefer to take measures such as saving or preserving and increasing value, so we will definitely conduct systematic research in this area. But now in China's wealth management market, we are still in the process of learning.
In terms of investment banking, currently it appears that investment banking is the most countercyclical field. Many financial institutions have been hit hard by investment banking, but Barclays' revenue is relatively stable because we have risk tolerance to support our business, balancing many unexpected commission income.
Therefore, in the next one or two years, we hope to use risk tolerance support as an anchor to more closely integrate Barclays' risk tolerance and investment banking business. This is also a trend in the global capital market, combining capital market activities with different banking and lending activities.
Interface news: The 10-year US treasury bond is known as the "anchor of global asset pricing". In 2023, the interest rate of the 10-year US treasury bond will exceed 5% for the first time in 16 years. Many domestic investors have shown great enthusiasm for investing in overseas financial markets. How do you view this?
Liu Yang: Many US dollar assets and other assets overseas are indeed very attractive and competitive.
The most fundamental aspect of the financial market is the 10-year interest rate in the United States, which has high volatility in 2023. Despite the decline in 10-year US Treasury yields in 2024, investing in overseas assets remains highly attractive to domestic investors in the relatively stable domestic macroeconomic environment of the renminbi.
Influenced by the high yield of the US treasury bond bonds in 2023, the bond products in 2023 do not need to have many fancy combinations. As long as they are simple, transparent and stable, they are already very popular in the market. This is also the most basic card Barclays will play in 2023.
However, there may be changes in the bond market in 2024. Considering the impact of the macro environment, if the Federal Reserve starts to cut interest rates, the overall bond interest rate market environment will fluctuate. Therefore, bond products will definitely become more diversified and complex this year.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Miniso has over 7000 global stores and will help 100 Chinese IPs go global in the future
- McDonald's China adds 640 new stores in the first three quarters of 2024, surpassing the same period in 2023
- NIO China increases capital to 7.43 billion yuan
- Lilly: The first and only non covalent (reversible) BTK inhibitor, Jeparil, has been approved in China
- Starbucks China leads global decline in same store sales, responds to 'abandoning price war'
- Continuing to target lower tier cities, Starbucks China enters 166 county-level markets in fiscal year 2024
- HSBC China: Starting from November 15th, applications for repricing cycle adjustment of existing personal housing loan interest rates will be accepted
- Sun Qiming, Vice President of China Western Promotion Association: Pinduoduo style logistics innovation activates the endogenous driving force of western economic development
- Grab Starbucks and Salia's business? Yum! China's third quarter revenue exceeded 20 billion yuan, with a significant increase in the proportion of franchise stores
- Baida Asset Management raises China and US stock ratings, optimistic outlook on economic outlook
-
【英偉達の需要が高すぎる?SKハイニックス:黄仁勲がHBM 4チップの6カ月前納入を要求!】SKハイニックスの崔泰源(チェ・テウォン)会長は月曜日、インビダーの黄仁勲(ファン・インフン)CEOが同社の次世代高帯域 ...
- 琳271
- 昨天 17:54
- 支持
- 反对
- 回复
- 收藏
-
ファイザーが前立腺がんを治療する革新薬テゼナ& ;reg;(TALZENNA®,一般名:トルエンスルホン酸タラゾールパーリカプセル)は2024年10月29日に国家薬品監督管理局(NMPA)の承認を得て、HRR遺伝子突然変異 ...
- 什么大师特
- 5 小时前
- 支持
- 反对
- 回复
- 收藏
-
南方財経は11月5日、中央テレビのニュースによると、現地時間11月5日、米ボーイング社のストライキ労働者が59%の投票結果で新たな賃金協定を受け入れ、7週間にわたるストライキを終えた。ストライキ労働者は11月12 ...
- Dubssgshbsbdhd
- 7 小时前
- 支持
- 反对
- 回复
- 收藏
-
【マスクはテスラが携帯電話を作ることに応えた:作れるが作らないアップルとグーグルが悪さをしない限り】現地時間11月5日、有名ポッドキャストのジョローガン氏のインタビューに応じ、「携帯電話を作るのは私たち ...
- 波大老师
- 8 小时前
- 支持
- 反对
- 回复
- 收藏